Oclacitinib as a corticosteroid-sparing agent in a cat with pemphigus foliaceus: A case report

Key Points

• To explore the use of oclacitinib as a corticosteroid-sparing treatment for a cat with pemphigus foliaceus.
• Case report of a cat diagnosed with pemphigus foliaceus.
• Initial treatment involved clinical observation and cytology without biopsy.
• Treatment progress monitored for efficacy of oclacitinib.
• Oclacitinib demonstrated effectiveness in reducing the need for corticosteroids.
• Clinical improvement observed in the cat's condition with ongoing oclacitinib treatment.